Opterion Health AG has appointed Björn Englund as chief executive officer, effective 6 April, succeeding the company’s founder Guido Grentzmann who will oversee scientific affairs. Opterion is developing a product for peritoneal dialysis, a procedure for removing waste products from blood when the kidneys don’t work. Mr Englund has recently been an industrial advisor at EQT Group Stockholm. He has also been managing director of Gambro Healthcare Sweden AB and vice president of the dialysis division of Euromedic.
Opterion announced the appointment on 25 March 2021.
Copyright 2021 Evernow Publishing Ltd